We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Dako, Merck Collaborate on CDx Test for Tumor Biomarker Analysis

News   Jun 02, 2014

 
Dako, Merck Collaborate on CDx Test for Tumor Biomarker Analysis
 
 
 

RELATED ARTICLES

Leukemia Stem Cells Rely on Amino Acids for Survival

News

Clinically relevant eradication of leukemia stem cells could be achieved with drugs that target their metabolic vulnerabilities.

READ MORE

Anti-Malaria Drugs Show Promise in Treating Cancer – Now We Know Why

News

Anti-malaria drugs known as chloroquines have been repurposed to treat cancer for decades, but until now no one knew exactly what the chloroquines were targeting when they attack a tumor. Now, researchers say they have identified that target - an enzyme called PPT1 - opening up a new pathway for potential cancer treatments.

READ MORE

Dramatic Increase in E-Cigarette Use Among Youth

News

Sharp rise in e-cigarette use results in uptick in overall tobacco product use; prompts new, forceful steps by FDA to firmly confront and reverse youth epidemic.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE